`
`Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
`
`FDA Home3 Drug Databases4 Orange Book-5
`
`Oran e Book: Approved Drug Products with Therazpeutic Equivalence Evaluations
`Searc results from the "OB_Rx ' table for query on "0 1688."
`
`Active Ingredient:
`
`Dosage Form;Route:
`
`Proprietary Name:
`
`Applicant:
`
`Strength:
`
`Application Number:
`Product Number:
`
`Approval Date:
`
`Reference Listed Drug
`RX/OTC/DISCN:
`TE Code:
`
`CINACALCET HYDROCHLORIDE
`
`TABLET;ORAL
`
`SENSIPAR
`
`AMGEN
`
`EQ 30MG BASE
`
`N021688
`001
`
`Mar 8, 2004
`
`No
`RX
`
`Patent and Exclusivity Info for this product: View
`
`Active Ingredient:
`
`Dosage Form;Route:
`
`Proprietary Name:
`
`Applicant:
`
`Strength:
`
`Application Number:
`Product Number:
`
`Approval Date:
`
`Reference Listed Drug
`RX/OTC/DISCN:
`TE Code:
`
`CINACALCET HYDROCHLORIDE
`
`TABLET;ORAL
`
`SENSIPAR
`
`AMGEN
`
`EQ 60MG BASE
`
`N021688
`002
`
`Mar 8, 2004
`
`No
`RX
`
`Patent and Exclusivity Info for this product: View
`
`Active Ingredient:
`
`Dosage Form;Route:
`
`Proprietary Name:
`
`Applicant:
`
`Strength:
`
`Application Number:
`Product Number:
`
`Approval Date:
`
`Reference Listed Drug
`RX/OTC/DISCN:
`TE Code:
`
`CINACALCET HYDROCHLORIDE
`
`TABLET;ORAL
`
`SENSIPAR
`
`AMGEN
`
`EQ 90MG BASE
`
`N021688
`003
`
`Mar 8, 2004
`
`Yes
`RX
`
`Patent and Exclusivity Info for this product: View
`
`Return to Electronic Orange Book Home Page5
`
`FDA/Center for Drug Evaluation and Research
`Office of Generic Drugs
`Division of Labeling and Program Support
`Update Frequency:
`
`Orange Book Data - Monthly
`Generic Drug Product Information & Patent Information - Daily
`Orange Book Data Updated Through December 2015
`
`Complex Innovations v. Amgen
`http://www .accessdata.fda.gov/scri pts/cder/ob/docs/obdetai I .cfm ?App|_N o= 021688&TABLE1= OB_Rx
`
`Amgen EX_ 2002
`
`|PR2016-00085
`
`Amgen Ex. 2002
`Complex Innovations v. Amgen
`IPR2016-00085
`
`
`
`1/28/2016
`
`Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
`
`Patent and Generic Drug Product Data Last Updated January 27, 2016
`
`Links on this page:
`
`1. http://www.addthis.com/bookmark.php?u508=true&v=152&username=fdamain
`
`2.
`
`http://www.addthis.com/bookmark. php
`
`3 4
`
`. http://www.fda.gov/defau|t.htm
`
`. http://www.fda.gov/Drugs/InformationOnDrugs/default.htm
`
`5.
`
`6 .
`
`../defau|t.cfm
`
`../defau|t.cfm
`
`Note: If you need help accessing information in different file formats, see Instructions for Downloading
`Viewers and Players.
`
`Accessibility Contact FDA Careers FDA Basics FOIA No Fear Act Site Map Transparency Website
`Policies
`
`U.S. Food and Drug Administration
`10903 New Hampshire Avenue
`Silver Spring, MD 20993
`Ph. 1-888-INFO-FDA (1-888-463-6332)
`Contact FDA
`
`V
`
`B .3 E .".
`
`For Government For Press
`
`Combination Products Advisory Committees Science & Research Regulatory Information Safety
`Emergency Preparedness International Programs News & Events Training and Continuing Education
`Inspections/Compliance State & Local Officials Consumers Industry Health Professionals FDA Archive
`
`£ U.S. Department of Health Bi Human Services
`
`Links on this page:
`
`1. http://www.addthis.com/bookmark.php?u508=true&v=152&username=fdamain
`
`2 3 4
`
`. http://www.addthis.com/bookmark.php
`
`. http://www.fda.gov/default.htm
`
`. http://www.fda.gov/Drugs/InformationOnDrugs/default.htm
`
`5.
`
`6 .
`
`../defau|t.cfm
`
`../defau|t.cfm
`
`http://www .accessdata.fda.gov/scri pts/cder/ob/docs/obdetai I .cfm ?App|_N o= 021688&TABLE1= OB_Rx
`
`2/2